Suein Choi
Seoul St. Mary's Hematology Hospital
Seoul, Republic of Korea
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Healthcare Jurisdiction as a Determinant of Real-World Survival in Transplant-Ineligible Multiple Myeloma: Lessons From a Three-Country East Asian Comparison.
Journal: European journal of haematology
Published: May 17, 2026
Population Pharmacokinetics and Model-Informed Precision Dosing of Lenalidomide Incorporating Total and Unbound Plasma Concentrations in Renally Impaired Patients with Multiple Myeloma.
Journal: Drug design, development and therapy
Published: February 27, 2026
Advancing siRNA Therapeutics with Pharmacometrics: A Review of Modeling Approaches and Clinical Applications.
Journal: Current gene therapy
Published: February 20, 2026
Risk prediction of traumatic and non-traumatic subdural hematoma after ischemic stroke: a nationwide competing-risk model with external validation.
Journal: Neurosurgical review
Published: January 27, 2026
A Simulation-Based Assessment of Dosage Regimen Appropriateness for Multiple Myeloma Medicines Reflecting Demographic and Ethnic Differences.
Journal: Clinical and translational science
Published: January 23, 2026
Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study.
Journal: Annals of hematology
Published: January 02, 2026
Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65-69 Years (CAREMM-2110 study).
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 19, 2025
Pharmacokinetic Equivalence of AmphosomTM, a Newly Developed Liposomal Amphotericin B, to AmbisomeⓇ.
Pharmacokinetic Equivalence of AmphosomTM, a Newly Developed Liposomal Amphotericin B, to AmbisomeⓇ.
Journal: Clinical therapeutics
Published: October 29, 2025
Real-World Outcomes of Tisagenlecleucel Versus Standard-of-Care Salvage Chemotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis From Korea.
Journal: Journal of Korean medical science
Published: September 11, 2025
Development and multinational validation of a multiple myeloma-specific comorbidity index using real-world cohorts: CAREMM-2108.
Journal: Blood cancer journal
Published: August 26, 2025
Beyond Michaelis-Menten: A modified enzyme kinetics equation improves drug metabolism prediction in bottom-Up PBPK modeling.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: July 16, 2025
Last Updated: 09/26/2026